ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stubborn low platelets after transplant?
Disease control Not yet recruitingThis study tests the drug baricitinib in 28 adults who have dangerously low platelet counts after a stem cell transplant and did not improve with standard treatments. The goal is to see if baricitinib can safely raise platelet levels enough to reduce the need for transfusions. Th…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Study to reveal if younger donors boost transplant success
Knowledge-focused Not yet recruitingThis study looks at how the age of a stem cell donor affects outcomes for people with blood cancers. Researchers will analyze data from 5,000 patients who received a first stem cell transplant, comparing those who got cells from younger versus older donors. The goal is to provide…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New study aims to uncover hidden superbug threat in transplant patients
Knowledge-focused Not yet recruitingThis study will follow 1,000 adults who have received a stem cell transplant to track a type of antibiotic-resistant bacteria called MBL-CRE. Researchers will use regular swab tests to see how often patients carry these bacteria and how often they develop infections. The goal is …
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Heart risks after stem cell transplants under the microscope
Knowledge-focused Not yet recruitingThis study will follow 400 people receiving a stem cell transplant to see how often they develop heart problems like heart attacks, irregular heartbeat, or heart failure. Researchers will use heart scans, blood tests, and other tools to find early warning signs. The goal is to be…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:45 UTC